Related Experiment Video
Updated: Jun 12, 2025

05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
738
Exploring Gua Sha Therapy for Chemotherapy-Induced Peripheral Neuropathy: A Single Case Report and Critical Analysis
Dan-Ni Wang1, Li-Fang Lei1, Jiao-Zhi Cai1
1Guangdong Provincial Hospital of Chinese Medicine.
Clinical Journal of Oncology Nursing
|September 26, 2024
Summary
Gua sha therapy significantly reduced chemotherapy-induced peripheral neuropathy (CIPN) symptoms in a single patient case. The intervention improved nerve function and provided lasting relief from numbness and tingling.
Area of Science:
- Integrative oncology
- Neurology
- Complementary and alternative medicine
Background:
- Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating side effect of cancer treatment.
- Current treatment options for CIPN are limited, necessitating exploration of novel interventions.
Purpose of the Study:
- This case study investigates the efficacy of gua sha as a potential intervention for managing CIPN.
- To document the impact of gua sha on a patient experiencing chemotherapy-related nerve damage.
Main Methods:
- A 38-year-old female patient underwent weekly 1-hour gua sha sessions for 10 weeks.
- Patient-reported outcomes were assessed using the FACT/GOG-NTX subscale.
- Objective measurements of limb numbness and tingling were recorded pre- and post-intervention, with extended follow-up.
Main Results:
- The patient's FACT/GOG-NTX subscale score improved significantly, increasing from 13 to 36, exceeding the minimum clinically important difference.
- Gua sha intervention led to a reduction in the extent of limb numbness and tingling.
- Symptom improvement remained stable at 18 months post-intervention, indicating sustained benefit.
Conclusions:
- Gua sha demonstrated a positive clinical effect in alleviating symptoms of CIPN in this patient.
- This case suggests gua sha may be a viable complementary therapy for managing chemotherapy-induced nerve damage.
- Further research is warranted to explore gua sha's therapeutic potential in larger patient cohorts.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
153
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
153
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181

